Opinion

Video

Lp(a) in Pediatrics

Key Takeaways

  • Pediatric lipid screening is vital for early dyslipidemia detection, reducing future cardiovascular disease risk.
  • Guidelines suggest universal screening at ages 9-11 and 17-21, with selective screening for at-risk children.
SHOW MORE

Panelists discuss how early identification of lipid disorders through pediatric screening is crucial yet underutilized, highlighting current guidelines and practical strategies to improve screening implementation in clinical practice.

Video content above is prompted by the following:

  • Can you describe the importance of pediatric lipid screening? What are the current recommendations and are they being implemented?
  • Are there practical strategies you could recommend to improve the uptake of pediatric lipid screening?
Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
4 experts are featured in this series.
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
© 2025 MJH Life Sciences

All rights reserved.